🔎 Trials Near Me

መነሻ › አኩት ሊምፎብላስቲክ ሊውኬሚያ › Washington › Seattle

በSeattle፣ WA ለአኩት ሊምፎብላስቲክ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች

ለአኩት ሊምፎብላስቲክ ሊውኬሚያ የሚደረጉ 21 ጥናቶች በSeattle እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

ተሳታዮችን በመፈለግ ላይ
  • Seattle Children's, University of Washington, Seattle
  • Fred Hutchinson Cancer Research Center, Seattle
እድሜ ከ1 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05621291

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • እና 1 ተጨማሪ
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Fred Hutchinson Cancer Center, Seattle
እድሜ ከ12 እስከ 78 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03802695

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Seattle Children's Hospital, Seattle
6 Months · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06514794

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Seattle Children's Hospital, Seattle
እስከ እድሜ 22 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04726241

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Seattle Children's Hospital d/b/a Seattle Children's Research Institute, Seattle
1 Day – 17 Years · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2026 · NCT06274788

Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኦገስ 2026 · NCT07224100

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
6 Months – 65 Years · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT06013423

Multicenter HomeVENT: Home Values and Experiences Navigation Track

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • Seattle Childrens Hospital, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ጁላይ 2026 · NCT06102330

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Fred Hutchinson Cancer Research Center, Seattle
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT01351545

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT03128034

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT03670966

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
6 Months · ሁሉም ጾታዎች · የተሻሻለው በ29 ሜይ 2026 · NCT04195633

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
እስከ እድሜ 80 · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT03326921

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Seattle Children's Hospital, Seattle
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT01790152

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Ascentage Investigative Site #1806, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ኤፕሪ 2026 · NCT06051409

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Fred Hutchinson Cancer Center, Seattle
እድሜ ከ18 እስከ 66 · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06859424

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
እድሜ ከ1 እስከ 60 · ሁሉም ጾታዎች · የተሻሻለው በ12 ማርች 2026 · NCT03970096

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Fred Hutchinson Cancer Research Center, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኖቬም 2025 · NCT04260022

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Fred Hutchinson Cancer Center, Seattle
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ኤፕሪ 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Seattle Children's Hospital, Seattle
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ6 ዲሴም 2024 · NCT05476770

በሌሎች ከተሞች ለአኩት ሊምፎብላስቲክ ሊውኬሚያ የሚደረጉ ጥናቶች

በSeattle ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።